TABLE OF CONTENTS
Volume 33, Issue 9 (May (1) 2004)
Progenitor Cell Mobilization |
Breast Cancer |
Non-Hodgkin's Lymphoma |
Infections Post Transplant |
Post-Transplant Complications |
Quality of Life |
Suicide Genes |
Case Report |
Correspondence
Reduced Intensity Conditioning Regimens
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease FREE
K B Miller, T F Roberts, G Chan, D P Schenkein, D Lawrence, K Sprague, G Gorgun, V Relias, H Grodman, A Mahajan and F M Foss
Bone Marrow Transplant 33: 881-889; advance online publication, March 1, 2004; doi:10.1038/sj.bmt.1704454
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies FREE
T Hamaki, M Kami, S-W Kim, Y Onishi, Y Kishi, N Murashige, A Hori, R Kojima, M Sakiyama, O Imataki, Y Heike, R Tanosaki, S Masuo, S Miyakoshi, S Taniguchi, K Tobinai and Y Takaue
Bone Marrow Transplant 33: 891-900; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704477
Progenitor Cell Mobilization
Effect of prior chemotherapy on hematopoietic stem cell mobilization FREE
C D Ford, W Green, S Warenski and F B Petersen
Bone Marrow Transplant 33: 901-905; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704455
Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma FREE
T Kuittinen, T Nousiainen, P Halonen, E Mahlamäki and E Jantunen
Bone Marrow Transplant 33: 907-912; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704466
Breast Cancer
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment FREE
F Bertucci, C Tarpin, E Charafe-Jauffret, V-J Bardou, A-C Braud, A Tallet, G Gravis, F Viret, A Gonçalves, G Houvenaeghel, D Blaise, J Jacquemier, D Maraninchi and P Viens
Bone Marrow Transplant 33: 913-920; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704458
Non-Hodgkin's Lymphoma
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma FREE
B Lemieux, S Tartas, C Traulle, D Espinouse, C Thieblemont, F Bouafia, Q Alhusein, D Antal, G Salles and B Coiffier
Bone Marrow Transplant 33: 921-923; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704467
Infections Post Transplant
Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation FREE
A Knöll, S Boehm, J Hahn, E Holler and W Jilg
Bone Marrow Transplant 33: 925-929; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704457
High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation FREE
V Hazar, S Kansoy, A Küpesiz, S Aksoylar, M Kantar and A Ye
ilipek
Bone Marrow Transplant 33: 931-935; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704463
Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients FREE
A C Tsiatis, B Manes, C Calder, D Billheimer, K S Wilkerson and H Frangoul
Bone Marrow Transplant 33: 937-941; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704462
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients FREE
C Cordonnier, S Maury, C Pautas, J N Bastié, S Chehata, S Castaigne, M Kuentz, S Bretagne and P Ribaud
Bone Marrow Transplant 33: 943-948; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704469
Post-Transplant Complications
Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning FREE
M A Slatter, A R Gennery, T D Cheetham, A Bhattacharya, B N A Crooks, T J Flood, A J Cant and M Abinun
Bone Marrow Transplant 33: 949-953; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704456
Quality of Life
Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation FREE
A C Sherman, S Simonton, U Latif, R Spohn and G Tricot
Bone Marrow Transplant 33: 955-962; advance online publication, March 22, 2004; doi:10.1038/sj.bmt.1704465
Suicide Genes
Escherichia coli-nitroreductase suicide gene control of human telomerase reverse transcriptase-transduced minor histocompatibility antigen-specific cytotoxic T cells FREE
R M Verdijk, M Wilke, V Beslier, A Kloosterman, A Brand, E Goulmy and T Mutis
Bone Marrow Transplant 33: 963-967; advance online publication, March 29, 2004; doi:10.1038/sj.bmt.1704470
Case Report
Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia FREE
E Mino, R Kobayashi, M Yoshida, Y Suzuki, M Yamada and K Kobayashi
Bone Marrow Transplant 33: 969-971; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704439
Correspondence
Prophylactic meropenem during neutropenia in allogeneic stem cell transplant recipients FREE
M Nucci, S A Nouér, M Garnica, A L M de Oliveira and A Maiolino
Bone Marrow Transplant 33: 973-974; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704459
